1. Home
  2. SNN

as of 03-04-2026 3:38pm EST

$36.36
$0.39
-1.06%
Stocks Health Care Industrial Specialties Nasdaq

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Founded: 1856 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 14.3B IPO Year: N/A
Target Price: $35.75 AVG Volume (30 days): 830.4K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
2.01%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $23.91 - $38.79 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 7.68% Revenue Growth (next year): 5.47%
P/E Ratio: 64.97 Index: N/A
Free Cash Flow: N/A FCF Growth: +40.59%

AI-Powered SNN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 75.47%
75.47%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: